青春期和成年期的桥梁:症过渡人口中的情绪障碍
Sarita Maturu1, Yevgeniya Gokun1, Richelle Collins2
1Neurology Department, The Ohio State University, Columbus OH, Ohio, USA.
Epileptic disorders : international epilepsy journal with videotape
|February 27, 2026
概括
患有的青少年和年轻人患有情绪障碍的患病率很高. 女性,20岁或以上,以及服用多种抗发作药物的患者的风险增加.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 青少年医学 青少年医学
背景情况:
- 患有的青少年和年轻人 (AYA) 通常难以自我管理,导致健康和社会状况不佳.
- 在AYA患者中,潜在的情绪障碍可能会使护理过渡复杂化,但关于其患病率和风险因素的数据有限.
研究的目的:
- 为了确定AYA患者焦虑和抑郁症的患病率.
- 在两个学术中心确定与这种人群中情绪障碍相关的风险因素.
主要方法:
- 来自两个三级保健中心的217名AYA患者 (年龄在16-26岁) 被录取.
- 患者完成了症过渡准备评估问卷 (EPI-TRAQ).
- 后勤回归分析了情绪障碍与年龄,性别和抗药物 (ASM) 使用等因素之间的关联.
主要成果:
- 28%的AYA患者被诊断患有情绪障碍.
- 与男性相比,女性患情绪障碍的几率是男性的2.2倍.
- 年龄较大 (≥20岁) 和使用两个或两个以上的ASM与情绪障碍的几率增加有关.
结论:
- 增加情绪障碍的监测对于AYA患者至关重要.
- 确定的关键风险因素包括女性性别,20岁以上和使用多种ASM.
- 建议对高风险个体进行早期干预和有针对性的支持.
相关概念视频
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Mania and Antimanic Drugs: Overview
708
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
708
Electroconvulsive Therapy
1.5K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.5K
Antiepileptic Drugs: Potassium Channel Activators
864
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
864
Bipolar Disorder
1.2K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K


